As of March 10, 2024, this course is no longer open for enrollment

As of March 10, 2024, this course is no longer open for enrollment


Continuing Education Credits

Course meets the requirements for 1 RACE hours of continuing education credit for veterinary technicians and veterinarians in jurisdictions which recognize AAVSB's RACE approval. However, participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery.

RACE Subject Category: Medical; Delivery Method: Non-interactive Distance; Program Number 944266.


Content Presenter

Rachel Venable, DVM, MS, DACVIM (Oncology)


Course Focus and Learning Objectives

Recent Advances in Veterinary Oncology: Updates Every General Practitioner Should Know is a free veterinary CE offering made possible through the generous educational support of PetDx®.

This course utilizes the archive of a live presentation.

This course provides an overview of recent advances in oncology. It discusses novel treatments and a new early cancer detection test. A review of the mechanism of action, study results, and uses of an oral treatment for canine lymphoma (Laverdia) along with an injectable treatment for canine mast cell tumor (Stelfonta) will be discussed. The course also provides a basic overview of cancer biology and introduces the fundamentals of blood-based “liquid biopsy” testing for canine cancer detection using next-generation sequencing of cell-free DNA (OncoK9). A review of the peer-reviewed clinical validation study of this testing in over 1,000 dogs is included.

After completion of this course, the student should be able to:

  • outline the basics of an oral canine lymphoma treatment including the results of studies and how to incorporate into daily practice
  • outline the basics of an injectable canine mast cell treatment including the results of studies and how to incorporate into daily practice
  • explain how cancer can be detected via blood sampling using advanced genomic technologies
  • discuss published clinical validation data for a next-generation sequencing-based blood test for detection of 30 different cancer types in dogs
  • explain how to use liquid biopsy testing in clinical practice


Open Enrollment with Immediate Access and Individual Scheduling

This is an open enrollment course. Participants may enroll at any time. Upon submission of enrollment the participant is immediately added to the course. The course welcome email provides login and other important information.

This is an asynchronous course, meaning it does not contain real time components. Participants do not need to be logged into the course at specific times to attend lectures or view presentations.

Participants do not need to complete the course in one sitting. However, students who do not access the course within 30 days of last access will be processed as incomplete. Any activity within the course will reset to the full 30 days time allotment.

Participants who are unable to complete a course may re-enroll at their convenience providing the course is still available.


Completion Requirements

The completion requirements for this course are:

  • complete the examination with a score of 80% or better - multiple attempts are permitted
  • submit the course survey

Upon submission of the final completion requirement, the participant will automatically be marked as completed and the course completion email will be sent out. The participant will have immediate access to the certificate.


Course Fee

Price: FREE